Protection of mice from the lethal effects of X-irradiation is obtained by the injection of isologous,l homologous, or closely related heterologous (rat) bone marrow shortly after X-ray exposure.2-4 Transplantation and repopulation of the donor's hematopoietic tissues in irradiated recipients has been demonstrated in experiments in which foreign bone marrow was used.5-12 Excellent recovery in terms of body weight and long-term survival is afforded lethally irradiated mice by postirradiation injection of isologous bone marrow (IBM). Lethally irradiated mice injected with homologous (HBM) or heterologous rat (RBM) bone marrow, although protected from radiation death, show an incomplete recovery as expressed by a marked secondary loss of body weight and high incidence of mortality occurring 3-6 weeks after treatment. Mice surviving this critical period, or "foreign bone marrow reaction" as it is commonly called, show a gradual return to normal body weight by about the sixtieth to seventieth day after treatment and in gross appearance may compare favorably with the isologously treated mice. The physiologic validity of this comparison was refuted in subsequent immunologic studies that showed a great divergence in the ability of these isologously and heterologously treated mice to produce antibodies to foreign red blood cell antigens (RBC). With 950 r-IBM"3 mice the injection of sheep or rat RBC antigens 30 days after treatment resulted in a normal immune response to sheep RBC but a subnormal response to rat RBC; injection of these antigens 60 days after treatment resulted in a normal response to both types. Thus, with respect to these two antigens, the immune mechanism of 950 r-IBM mice returned to a relatively normal status 60 days after treatment. " The response of the 950 r-RBM mice to sheep RBC, however, was considerably below normal when the antigens were injected 30 days after treatment; there was no improvement in response of a second group of mice injected 60 days after treatment. This suggests a definite impairment of the immune mechanism.'5
tion of isologous,l homologous, or closely related heterologous (rat) bone marrow shortly after X-ray exposure.2-4 Transplantation and repopulation of the donor's hematopoietic tissues in irradiated recipients has been demonstrated in experiments in which foreign bone marrow was used.5-12 Excellent recovery in terms of body weight and long-term survival is afforded lethally irradiated mice by postirradiation injection of isologous bone marrow (IBM). Lethally irradiated mice injected with homologous (HBM) or heterologous rat (RBM) bone marrow, although protected from radiation death, show an incomplete recovery as expressed by a marked secondary loss of body weight and high incidence of mortality occurring 3-6 weeks after treatment. Mice surviving this critical period, or "foreign bone marrow reaction" as it is commonly called, show a gradual return to normal body weight by about the sixtieth to seventieth day after treatment and in gross appearance may compare favorably with the isologously treated mice. The physiologic validity of this comparison was refuted in subsequent immunologic studies that showed a great divergence in the ability of these isologously and heterologously treated mice to produce antibodies to foreign red blood cell antigens (RBC). With 950 r-IBM"3 mice the injection of sheep or rat RBC antigens 30 days after treatment resulted in a normal immune response to sheep RBC but a subnormal response to rat RBC; injection of these antigens 60 days after treatment resulted in a normal response to both types. Thus, with respect to these two antigens, the immune mechanism of 950 r-IBM mice returned to a relatively normal status 60 days after treatment. " The response of the 950 r-RBM mice to sheep RBC, however, was considerably below normal when the antigens were injected 30 days after treatment; there was no improvement in response of a second group of mice injected 60 days after treatment. This suggests a definite impairment of the immune mechanism. '5 To establish the temporary or permanent nature of this lowered immune response among mice treated with foreign bone marrow and consequently to contribute to a better understanding of the mechanism involved, we began a study of the immune status of long-term survivors (200-300 days posttreatment) of lethally irradiated mice treated with isologous, homologous, or heterologous rat bone marrow. MATERIALS Serology.-All long-term survivors used in this study were in excellent condition as indicated by body weight and gross appearance. Immediately before antigen injection, the peripheral blood of the mice treated with foreign bone marrow was tested for circulating donor type RBC, the technique described by Makinodan6 being used for the 950 r-RBM mice and a dextran-human serum hemagglutination and hemolysin technique (Owen, unpublished data) for the 950 r-HBM mice. At intervals of 200-300 days after irradiation and bone marrow treatment, each mouse received a single intraperitoneal injection of 1 ml. of a 12 per cent suspension of sheep or rat RBC. The limited number of survivors among mice treated with foreign bone marrow made a complete antibody production curve infeasible. Instead, mice were bled 18 days after antigen injection,'4 and the serum was titrated for agglutinating antibodies. We thought that this single-point bleeding would suffice, for the purpose of this study, in establishing the relative immune status of the three different groups of irradiated-marrow treated mice.
The agglutinin titration procedure involved the twofold serial dilution method.'4 The reciprocal of the highest dilution of serum giving a definite macroscopic agglutination was defined as the titer, which was then converted to log2 titer. The statistical analysis was performed by the "Student" t-test, and the difference in response between any two groups was considered significant if P < 0.01.
Autopsy.-Some of the mice used in this study were autopsied after being bled to obtain serum. The tissues were fixed in Zenker-formol solution. The sections were stained with hematoxylin and eosin.
RESULTS
The data are shown in Table 1 . The individual titers are tabulated to show the range in agglutinin response in each experimental group. Among the 950 r-IBM mice the immune response to sheep and rat RBC antigens was comparable to that of the normal age group. The 950 r-HBM mice showed a significantly lower response to both sheep and rat RBC than did the 950 r-IBM mice. The response of 950 r-HBM mice to sheep RBC was significantly greater than to rat RBC. A considerable depression of the immune response to sheep RBC was observed in the 950 r-RBM mice, and three mice failed to produce any detectable antibody. The mean sheep agglutinin titer for this group was also significantly lower than that obtained with the 950 r-HBM mice. The log2 titer of 2.3 for the 950 r-RBM mice is comparable to the 2.6 and 2.9 log2 titers obtained with antigen injection 30 and 60 days after treatment, respectively, in a previous study with heterologously treated mice. 1" VrOL. 44, 1958 56;1 All foreign bone marrow-protected mice used in the present study showed 100 per cent donor-type RBC in the peripheral blood at time of antigen injection. Two additional 950 r-RBM mice that had 100 per cent host (mouse) type RBC in their circulation 200 days after treatment were also injected with sheep RBC. The agglutinin log2 titer of these two was 7.0, comparable to the normal control group (data not tabulated).
Autopsy examination of 19 mice from the 950 r-IBM group revealed a normal appearance of the hematopoietic and lymphatic systems. Twenty-four mice from the 950 r-HBM series showed marked atrophy of nearly all lymphatic tissues, with The absence of typical reactive changes as seen during the "foreign bone marrow reaction" in most of the long-term homologously treated mice would seem to favor a state of tolerance. Additional histologic studies on these long-term survivors of the foreign marrow-treated mice is indicated, and a comprehensive study is in progress.
The second postulate, that a persisting in vivo antigen-antibody reaction exists in these mice and results in a lowered state of immunologic reactivity, is formulated as follows: During the period of secondary loss of body weight and increased deaths characterizing the "foreign bone marrow reaction," the in vivo balance of antigen and antibody is at the optimum proportion necessary to effect this delayed immune reaction. Gradually this balance is shifted, as an excess of antigen (rela-tive or absolute) offsets the fine equilibrium of antigen and antibody required in vivo to give the delayed type of reaction.27 The animals recover at this time. The physical manifestations of such an "in vivo antigen excess phenomenon" need not be apparent, either at the gross anatomical level or in histologic examination of the tissues. Such a reaction, however, would place a physiologic stress on the animal's immune mechanism and might result in a subnormal response to unrelated antigens. The difference in response to sheep and rat RBC in the 950 r-HBM mice may be described in terms of the recognition factor postulated by Makinodan et al.; '4' 21 i.e., a greater response to the more distantly related antigen (sheep RBC) may occur when the immune mechanism is placed under severe stress. The ability of the 950 r-HBM mice to produce more agglutinins to sheep RBC than the 950 r-RBM mice suggests a quantitative expression of this stress on the antibody-forming mechanism. Thus the genetic relation between host and graft may be reflected in the degree of physiologic stress created by this in vivo reaction. The association of the continued presence of the foreign graft with this effect is evident in the normal immune response to sheep RBC in two 950 r-RBM mice which had sloughed their grafts prior to antigen injection. Additional observations supporting the concept of a persisting in vivo antigen-antibody reaction are (a) the changing proportions of donor and host RBC in the peripheral blood of several foreign bone marrow chimeras28' 29 and (b) the complete reversal to mouse-type cells that we and others have noted in a small percentage of the 950 r-RBM mice. Indeed, as indicated by Makinodan,'0 the foregoing observations themselves make it difficult to conceive of a state of "tolerance" in these mice.
The results of this study suggest a re-evaluation of the concept of tolerance as applied to the long-term survivors of the foreign marrow-protected mice. The 1957 review by Owen3' on immunologic tolerance makes apparent the complexities among the various phenomena concerned with modifications of the host's immune response and accordingly cautions one against equating their mechanisms of reaction. Thus, instead of clasifying and typing the foreign marrow-protected mice as "tolerant" or in a state of immunologic "paralysis,"it seems advisable to maintain a separate identity for these phenomena until further investigations provide tests for definitive relationships.
SUMMARY
The immune status of lethally irradiated mice treated with isologous, homologous, or heterologous rat bone marrow was studied by injecting sheep or rat RBC antigens into the protected mice 200-300 days after treatment. The results showed the foreign bone marrow-protected mice to have a subnormal immune mechanism, provided that the foreign transplant persisted in these animals, whereas the isologously treated mice responded in a normal manner.
Two postulates are considered in the interpretation of this subnormal immune mechanism: (1) the lowered immune response is a quantitative expression of the functional antibody tissue remaining in these mice after recovery from the foreign hone marrow reaction, or (2) an in vivo antigen-antibody reaction persists in these animals and consequently affects their ability to respond normally to other antigens. Emphasis is placed on a re-evaluation of the concept of tolerance as applied to the long-term survivors of the foreign marrow-protected mice. 
